Overview


According to FutureWise analysis the market for advanced clinical decision support platforms is expected to reach US$ 1.31 billion by 2031 at a CAGR of 8.90%.

Clinical decision support (CDS) is the critical support system that enhances health-related decisions and actions with pertinent, organized clinical knowledge and patient information in a well-mannered way to improve health and healthcare delivery system facilities. It is a health information technology that aids with the proper knowledge and personalized information, making it easy for healthcare professional teams, patients, and others to make informed decisions. It includes a wide range of tools designed to improve decision-making within the clinical setup. This arrangement is made with computer-generated alerts and reminders for the healthcare professional team and the patients, clinical guidelines, sets of orders in a specific way for particular conditions, summarized patient data, customizable documentation templates, diagnostic assistance, and contextually relevant reference materials, among other resources. CDSS plays a significant role in the field of artificial intelligence in medicine. It includes specific vital characteristics such as an active knowledge system that refers to the patient data variables to provide recommendations related to healthcare. It essentially serves as a decision support system with focused knowledge management.

A CDSS is an active knowledge system that utilizes patient data variables to provide recommendations related to healthcare. It serves as a decision support system with a focus on knowledge management. The primary concern of modern CDSS is to assist clinicians during patient care by interacting with the CDSS to analyze patient data for various diseases and reach an accurate diagnosis. The primary objective of modern CDSS is to assist clinicians during patient care. This means that clinicians interact with a CDSS to analyze patient data for various diseases and reach a diagnosis. Typically, a CDSS offers suggestions for clinicians to review, and the clinician is responsible for identifying valuable insights among the results and disregarding any erroneous CDSS suggestions. There are two primary types of CDSS: knowledge-based and non-knowledge-based systems. The knowledge base comprises compiled data from IF-THEN rules, encompassing guidelines and associations. In contrast, the newer CDSSs do not rely on a knowledge base but instead utilize artificial intelligence, a type of machine learning that enables computers to learn from past experiences and identify patterns within clinical data.

FutureWise Market Research has published a report that provides an insightful analysis of Advanced Clinical Decision Support Platforms Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Advanced Clinical Decision Support Platforms Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
  • CERNER CORPORATION
  • RELX GROUP (ELSEVIER B.V.)
  • EPIC SYSTEM CORPORATION
  • IBM WATSON HEALTH
  • MEDITECH
  • NEXTGEN HEALTHCARE, INC.
  • SIEMENS HEALTHINEERS AG
  • WOLTERS KLUWER HEALTH
  • ZYNX HEALTH

(Note: The list of the major players will be updated with the latest market scenario and trends)
 

Recent Development in Advanced Clinical Decision Support Platforms Market:

  • In 2022, Allscripts, a US-based healthcare technology company, agreed to divest Constellation, a Canadian entity, and the net assets associated with its Hospitals and Large Physician Practices business segment. This particular business segment encompasses a range of healthcare solutions, including Sunrise TM Paragon®, Allscripts TouchWorks®, Allscripts® Opal, START, HealthQuest™, and dbMotion TM.
  • In 2021, Change Healthcare, another US healthcare company, introduced InterQual in collaboration with the American Society of Addiction Medicine (ASAM). InterQual was designed to seamlessly integrate into existing care management workflows, simplifying and expediting substance use disorder (SUD) patient assessments. It enhances assessment consistency and streamlines the prior authorization process using industry-standard criteria.

The continuous, ever-rising pool of the healthcare industry is initiating more and more opportunities for the CDSS market by adapting widespread adoption of electronic healthcare records and digitalization of medical information. These systems are excellent data analysis sources, offering invaluable insights to healthcare providers for informed decision-making. The intensified emphasis on patient safety, driven by accurate healthcare record outcomes by reducing medical errors, is boosting the adoption of CDSS. These systems are equipped to provide real-time guidance and alerts, acting as vigilant partners for healthcare professionals in their clinical practices. Another trend advancement in this field is using artificial intelligence and machine learning technologies, again fuelling the market growth. CDSS offers a wide range of opportunities, such as clinical decision-making, by identifying the patterns and trends within the patient data that may not be known with the traditional methods. It enhances the treatment strategies by working on disease management, patient care, and improved patient outcomes, thus boosting market growth.

However, despite these promising drivers, the CDSS market faces significant challenges. The complexity associated with implementing and integrating CDSS into existing healthcare systems is a noteworthy restraint. This process often demands substantial financial investments and technical expertise, posing barriers for smaller healthcare institutions. Data security and privacy are also mandatory concerns related to the CDSS, which requires proper security management, again hampers the market growth.

By Type

  • Therapeutic
  • Diagnostic

By Model

  • Knowledge based
  • Non-Knowledge based

By Setting

  • Hospitals
  • Ambulatory care

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process. 

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America's advanced clinical decision support platforms market share is expected to grow during the forecast period due to a rise in populations suffering from chronic disorders such as cancer, cardiovascular diseases, diabetes, and others. Thus, providing the most significant factor responsible for driving the application of advanced clinical decision support platforms in hospitals for diagnostic and therapeutic purposes and propelling the market growth. In addition, the rise in product provision for clinical decision-support platforms in cancer fuels the market growth of advanced clinical decision-support media. The Asia-Pacific advanced clinical decision support platform market is expected to experience growth during the forecast period due to low operating costs and economic development. The significant factors that fuel the market growth in this region include a surge in persistent ailments such as cardiovascular diseases, cancer and the rising geriatric population more susceptible to chronic diseases. In addition, the increasing demand for cost-effective healthcare services and the need to reduce healthcare costs have driven the growth of the advanced clinical decision support platform market in the Asia Pacific region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Advanced Clinical Decision Support Platforms Market By Type, By Model, By Setting and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Advanced Clinical Decision Support Platforms Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Advanced Clinical Decision Support Platforms Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Advanced Clinical Decision Support Platforms Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Advanced Clinical Decision Support Platforms Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Therapeutic
        2. Diagnostic

  • 8.   Advanced Clinical Decision Support Platforms Market, By Model Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Knowledge based
        2. Non-Knowledge based

  • 9.   Advanced Clinical Decision Support Platforms Market, By Setting Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory care

  • 10.   North America Advanced Clinical Decision Support Platforms Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Advanced Clinical Decision Support Platforms Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Advanced Clinical Decision Support Platforms Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Advanced Clinical Decision Support Platforms Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. CERNER CORPORATION
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. RELX GROUP (ELSEVIER B.V.)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. EPIC SYSTEM CORPORATION
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. IBM WATSON HEALTH
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. MEDITECH
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. NEXTGEN HEALTHCARE, INC.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. SIEMENS HEALTHINEERS AG
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. WOLTERS KLUWER HEALTH
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. ZYNX HEALTH
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Clinical Decision Support Systems Market

Read More
Partner

Our Clients